Professional Documents
Culture Documents
6.30 – 6.45pm Welcome & Introduction - The Dr Karen McEwan, Planned Care GP
Management of Long COVID Lead, Stockport CCG
6.45 – 7pm COVID Recovery; a Respiratory Dr Vandana Gupta, Consultant Chest
Perspective Physician, Stockport FT
7pm – 7.15pm Managing Post COVID Marie Gregory, Clinical Lead
Breathlessness Physiotherapist, Stockport
Pulmonary & HF Rehabilitation
Service
7.15 – 7.30 Long COVID -19 and Fatigue Tina Betts CFS/ME Physiotherapist,
Stockport CFS/ME Service
7.30 – 7.45 Psychological Care - Recovery from Dr Paul Hood, Clinical Psychologist,
COVID-19 & Long-COVID Stockport FT
7.45 – 8pm Q&A and Close Whole Panel
Management of Long
Covid
Dr Karen McEwan
Aims and Objectives
Useful Resources
Radiological follow-up will not change management for some patients (e.g.
with severe cognitive impairment, limited life expectancy <6 months, unlikely
to be troubled with breathlessness due to severely limited mobility). These
patients should be assessed on a case-by-case basis using a patient-centred
approach focusing on symptom review and management.
PATHWAY
*Patients with COVID-19 may be at risk of
developing ILD and/or pulmonary HTN. Radiological evidence of COVID-19?
Radiological follow-up will not change CXR or CT shows classical/probable changes consistent with Patients with lobar
NO
outcomes in some, and treatment options COVID-19 AND confirmed/presumed COVID-19 consolidation on CXR should
may be limited for some patients (e.g. be followed-up with 6/52 CXR
patients with severe cognitive impairment, as per usual pathways.
patients with limited life expectancy <6 YES
months, patients unlikely to be troubled with
breathlessness due to severely limited Give safety netting advice and PIL
mobility). These patients should be assessed See GP if persistent >6 weeks, worsening, or new onset respiratory
on a case-by-case basis using a patient- symptoms (cough, breathlessness, chest pain, haemoptysis).
centred approach focusing on symptom Patient-centred symptom
review and management. review. Consider symptomatic
NO treatment. Consider referral to
Would the patient benefit from radiological follow-up?* rehabilitation.
YES
AMBER (mild/moderate COVID RED (severe COVID pneumonitis)
AMBER AND
pneumonitis)
Confirmed PE
6/52 virtual FU with respiratory. If ICU/HDU
Primary care phone call at 6 weeks admission will also have ICU FU clinic to assess
psychosocial needs and multisystem review
3/12 repeat CXR (requested on
discharge by ward team)
COVID clinic review 3/12 with repeat
CXR report reviewed by referring CXR
Consultant
NORMAL/
IMPROVED NORMAL/
PERSISTENT SIGNIFICANT PERSISTENT
IMPROVED SYMPTOMS/CXR CHANGE
ILD/PH?
CXR CHANGE
38 no symptoms
33 CXR/CT resolution
2 resolving changes
1 mild fibrosis
2 Awaiting HRCT
19 SOB
10 CXR/CT resolution
5 resolving changes
1 severe fibrosis
3 awaiting HRCT
2 DNA
Clinic outcomes: Long covid patients
• GP referrals
• Ongoing SOB, cough, chest pain
• Covid clinic/ Breathlessness clinic
• 10-15 patients
• PFTs normal
• CT normal so far
Long term respiratory symptoms
• ONS figures 21% symptomatic at 5 weeks and 9.9% at 12
weeks (ons.gov.uk)
• Covid symptom study app data: 4200 cases, 13.3% had
symptoms >4 weeks, 4.5% >8 weeks, 2.3% >12 weeks
(Sudre et al 2020)
• 3700 patients, international patient led study (Davis et al
2020, may have had negative test);at 7 months
- SOB 37.9%
- Cough 20.1%
- Chest pain 23.1%
NICE guidance
PFT and CT abnormalities
n Time Country Severity Findings Reference
(months)
55 3 China Mod-severe 25% PFT and Zhao et al
71% HRCT 2020
abnormality
60 3 Canada Mod-severe 58% PFT and Shah et al
55% HRCT 2020
abnormality
125 3 Netherlands 79% mod- 99% resolving Van den
severe CT changes, Borst et al
16% desaturate 2021
on 6MWT
350 6 China 75% severe 22% PFT and Huang et al
50% HRCT 2021
abnormality
• Increased coagulopathy in hospitalised
patients
• Increased arterial and venous thrombosis in
severe and non severe disease
• Microthrombi seen in lungs, heart, liver and
kidney
• CTPA can miss small vessel/subsegmental PE
• Recommend perfusion imaging (V:Q, dual
energy CT)
MR abnormalities
• Unpublished data (COVERSCAN, Dennis et al
2021)
-201 patients (Oxford/London)
- 18% hospitalised
- 3 months, 87% SOB
- MR scan used to diagnose organ
impairment: lungs (33%), heart (32%), pancreas
(17%), kidney (12%), liver (10%)
Xenon scans
• 40 patients
• Sheffield/Oxford
• PHOSPH-COVID (national covid follow up
study)
• Hyperpolarised xenon with MRI to identify
oxygen diffusion in alveoli
• Full results awaited
Mast cell activation syndrome (MCAS)
Exam
•Bibasal creps, wheeze, red flags eg clubbing, lymphadenopathy
•Murmurs, oedema
•Sats at rest and after exercise (if desaturates more suggestive of respiratory disease)
Investigations
•CXR (doesn’t exclude lung disease if normal)
•ECG
•Sputum MC+S
• Bloods FBC, UE, LFT, CRP, TFT, BNP, Ferritin
Patient Presentation
• Variable from person to person:
General health, hospitalised with Covid infection, pathological changes to
lung tissue, deconditioning, raised BMI
• By 6 weeks post infection, most show substantial improvement, but can take 3-
6 months to fully resolve. Beyond this: Long Covid
Post Covid breathlessness
• 14 patient referrals – direct from ITU follow up or Chest Clinic. 9 patients seen
• Required high level of input: cardiology, pain management, CFS /ME service, psychology,
GP
Pre-covid baseline
compared to post covid – No change /slight Severe
Slight /moderate decline Moderate decline
physical ability & decline decline
breathlessness.
Breathing control
• Comfortable position, relaxed shoulders.
• Hand on tummy & chest
• Steady breaths in through the nose, feel tummy rise
• Relaxed out breath out through the mouth.
Blow as you go/ Purse lip breathing – Breath out on the main effort
Pacing – Slow down, break tasks down, regular short breaks as opposed to fewer
prolonged breaks.
Other Hints and tips - cool wet flannel on cheeks and nose, fresh air,
relaxation/mindfulness, encourage staying calm/controlling anxiety
(fan therapy not recommended)
Breathlessness management
Online resources
13% of people with COVID may go on to experience symptoms 28 days post infection
Symptoms:
• Fatigue
• Neurological: Headache, brain fog, neuropathy
• CV: Shortness of breath, chest pain/ palpations / tachycardia/bradycardia
• Fever
• GI
• MSK, pain, weakness deconditioning
• ENT: Loss of smell, tinnitus,
• Psychiatric, primary? secondary? adjustment?
https://www.kcl.ac.uk/news/study-identifies-those-most-risk-long-covid
and
https://
www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid1
9-pdf-66142028400325
Presentation
• Expected Recovery
• Risk Factors
• Symptoms
– Fatigue
– Breathlessness and cough
– Deconditioning
• What is the CFS/ME service doing?
• Summary
Expected Recovery
Fatigue
Chronic
Fatigue
CFS
Fatigue
Fatigue-Safety Valve?
• An acute experience of exhaustion, it is a protective
response to physical and or psychological stress, and
illness.
• Resolved by rest and recovery.
• Managed by switching between activities physical
and mental
• Fatigue experience fluctuates from hour to hour, day
to day
Chronic Fatigue
Emerging Presentation
• Physical:
– Loss of muscle mass through illness,
– Deconditioning: illness behaviour/ lock-down restrictions
– Ongoing symptoms: breathlessness, cardiac….
• Cognitive:
– Cognitive processing of completing a task, e.g. going shopping, home schooling, returning to work
feels too much
– Memory and concentration
• Psychological and Emotional:
– Frustration: what is wrong with me? What have the Drs missed?
– Fear, anxiety, low mood
– Depressive symptoms
CFS
Once alternative fatigue causing COVID complications have been considered and
eliminated consider a diagnosis of Chronic Fatigue (Syndrome?)
Symptoms of CFS:
https://www.yourcovidrecovery.nhs.uk/
Breathing Problems
Once significant lung disease/damage has been excluded as causative – management can follow:
Breathlessness:
–Breathing and resting recovery positions to ease effort of breathing
–Nose and diaphragmatic breathing – breathing rhythm
–Breathing rectangle
–Relaxation
–Blow-as-you-go, pacing your breathing with activity
Cough:
may persist due to increased sensitivity throat and upper airways, remove triggers:
–Nose breath, to moisten and filter the air
–Sip water
–Suck sweets
–Relaxed breathing postures: such as forward lean sitting
–Relaxation
–Rhythmic cycles of breathing
https://www.yourcovidrecovery.nhs.uk/
Deconditioning
Deconditioned weak muscles compromise recovery, maintain breathlessness and
prevent return to normal function - encourage:
Bmj: Returning to physical activity after COVID –exercise should be undertaken with caution
https://www.bmj.com/content/372/bmj.m4721.full?ijkey=zg3oXn8zXc3doU1&keytype=ref
Service action
• Identify the need for fatigue management in an effort to minimise the
risk of developing CFS
• Service review of activity to identify if there was capacity and capability
to provide single session fatigue management /assessment and advice
• Patient information leaflet on fatigue using best available evidence,
based on PVFS
• EMIS template – ensure we captured the assessment data relevant to
the input we could deliver
• Mail shot GP to inform them of service availability
• Triage referrals – patients to be allocated to most appropriate MDT
clinician
• Single session Covid Fatigue Management
Service impact
• Evaluation of skills within the team, and understand
what skills were transferable to manage COVID fatigue;
L&D to understand Long COVID-19 and management
interventions from sources such as
– Health Education England e-learning
– RCGP Learning,
– IAPT, webinars
– BTS
• Referrals to date 26 – single session fatigue
management consultation
Findings
• Approximately 2.5 hours per patient (excluding
clinician learning)
• 4 Long COVID -19 patients diagnosed with CFS??
• Recurrent symptom presentations: chronic fatigue,
physical deconditioning, breathlessness/cough
• Complexity of symptoms - patients requiring further
support
• Service impact/data collection – supported by CFS/ME
administrator
Referral Data 28/01/21
Male: 10
Female: 15
16
14
12
10
8
Male
6 Female
0
Gender
Referral Data 28/01/21 Age
0-20: 1
21-30: 2
8 31-40: 4
41-50: 5
7
51-60: 7
6
61-70: 4
71-80: 2
5
4
0-20
3 21-30
31-40
2
41-50
51-60
1
61-70
0 71-80
Age
Referral Data 28/01/21 Referral Received
July 2020 - 1
August 2020 - 2
September 2020 - 0
12
October 2020 - 6
November 2020 - 2
10
December 2020 - 4
January 2021 - 10
8
6
Jul-20
Aug-20
4 Sep-20
Oct-20
2 Nov-20
Dec-20
Jan-21
0
Referral Received
Referral Data 28/01/21 Covid Infection
Unknown - 1
March 2020 - 6
7 April 2020 - 6
May 2020 - 4
6 June 2020 - 1
July 2020 - 0
5 August 2020 - 4
September 2020 - 1
4 October 2020 - 2
Unknown
3
Mar-20
Apr-20
2 May-20
Jun-20
Jul-20
1
Aug-20
Sep-20
0 Oct-20
COVID Infection
CFS Interventions
Summary
Dr Paul Hood
Title of Presentation goes here
Clinical Psychologist
Stockport NHS Foundation Trust
Objectives
- Fatigue
- Joint & chest pain
- Breathlessness
Community post-COVID
Relationship
Depression 20-40% Difficulties 15-25%
Sleep
Anxiety 30-50% Problems 40-60%
Adjustment
PTSD 2-5% Disorder
30-40%
Memory &
Fear of
20% 15-25%
Concentration
COVID
Hospital Discharged Pts
Interpersonal
Depression 40% Difficulties ?%
Sleep
Anxiety 33% Problems ?%
Adjustment
PTSD 20% Disorder
?%
Memory &
Fear of
30% 20-50%
Concentration
COVID
ICU-FU Pts ~3mths
Relationship
Depression 40% Difficulties 30-50%
Sleep
Anxiety 33% Problems 50-70%
PTSD Adjustment
Symptoms
15-30% Disorder
20-40%
Memory &
Fear of
30-60% Concentration
50%
COVID
Healthcare Frontline Staff
Relationship
Depression 30-50% Difficulties 29%
Fear of
COVID
50-80%
Factors
NICE guideline [NG188] COVID-19 rapid guideline: managing the long-term effects
of COVID-19. Published date: 18 December 2020
UK Government (2020). COVID-19: guidance for the public on mental health and
wellbeing.
• Bio-psycho-social approach
GP Appointments
• Open questions
• Attempt to establish rapport
• Active listening and positive regard
• Explore problems (panic, poor sleep, flashbacks, frightened to go out)
• Explore ICE (Ideas, Concerns, Expectations)
• Does patient have access to post-ICU clinic?
• Assess severity of symptoms (PHQ9 and GAD7)
• Consider physical health (e.g. diabetes control)
• Assess risk
• Reflection and summarise (e.g. memory and concentration)
• Discuss options – e.g. antidepressants and referral to psychosocial servivr
• Safety plan if required
• Book follow-up appointment if required
Service Options
Educational resources
Self-Care Signposting to activities / wellbeing
Multi-service collaboration
Complex Cases Bespoke intensive / longer term care
planning
Resources (T1)
https://www.yourcovidrecovery.nhs.uk/
SERVICE
DIRECTORY
QUICK GUIDE TO THE LOCAL SERVICE OFFER FOR
NEIGHBOURHOOD TEAMS
Resources (T2)
https://www.viaductcare.org.uk
Tel. 0161 204 4675 or Self referrer on website
www.iaptportal.co.uk/ServiceUser/SelfReferralForm.aspx
www.penninecare.nhs.uk/healthymindsstockport
Tel. 0161 204 4675 or Self referrer on website
www.stockport.nhs.uk
Tel. 0161 419 5015 SPMS@Stockport.nhs.uk
www.stockport.nhs.uk
ICU@stockport.nhs.uk Follow-up & networked service
www.penninecare.nhs.uk/stockportaccessteam
Tel. 0161 419 4678 or Referral via GP/health professionals
Any Questions?
Questions & Close